3Thomas HC.Lok ASF.Carreno V.et al. Comparative study of three doses of Interferon α2a in chronic active hepatitis B[J].J Viral Hepatitis,1994,1:13 9～48
4Williams SJ.Craig PI,Cooksley WGE,et al. Randomized controled trial of Recomb inant human interferon-α-A for chronic active hepatitis B[J].Aust N Z J Med, 1990,20:9～19
5Tealdi G,Fattovich G,et al. Problems in the management of chronic hepatitis B with interferon:experience in a randomized, multicentre study[J]. J Hepatol,1 990,11(1):129～32
6Rumi M, Romeo R,De-Filippi F, et a.A multicentre randomized clinical of recomb inant alpha-2a interferon therapy in patients with chronic hepatitis B[J].Ital J Gastroenterol,1993;25:117～20
7Wu PC, Lok AS, Lau JY,et al, Histologic changes in Chinese patients with chron ic hepatitis B virus infection after interferon-alpha therapy[J]. Am J Clin pa thol,1992,(4):402～7
8Lai CL, Lin HJ, Lau JN,et al. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children[J]. Q J Med,1991,78 (286):155～63
9Lok AS, Lai CL, Wu PC,et al. Alpha-interferon treatment in Chinese patients wi th chronic hepatitis B infection in children and oriental patients[J].J Gastro enterol Hepatol,1991,6(1):15～7
10Lok AS,Lai CL, Wu PC, et al. Alpha-interferon treatment in Chinese patients w ith chronic hepatitis B[J]. J Hepatol,1990,1:121～127
8Ishak KG. Pathologic features of chronic hepatitis. A review and update[J] .Am J Clin Pathol, 2000, 113 (1) :40.
9Lai CL,Dienstag J ,Schiff E,et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B[J] . Clinical Infectious Diseases, 2003,36(6) : 68.
10Hadziyannis S, Tassopoulos N, Chang TT, et al. Long - term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HbeAg negative chronic hepatitis B: results after 5 years of therapy[J]. Hepatology, 2005,42(Suppl 1 ) : A14.
